Moreover, a high expression of α3β1 and/or its laminin ligands has been associated with poor outcomes in SCCs and breast cancer, implicating α3β1 as a potentially useful prognostic marker [20,22,23,24,25,28,29,44,53,54,55]. The gene discussed is LAMB2; the disease is breast cancer.